Italia markets close in 2 hours 46 minutes

Cipla Limited (CIPLA.BO)

BSE - BSE Prezzo in tempo reale. Valuta in INR.
Aggiungi a watchlist
1.347,65-28,40 (-2,06%)
Alla chiusura: 03:29PM IST

Cipla Limited

Cipla House
Peninsula Business Park Ganpatrao Kadam Marg Lower Parel
Mumbai 400013
India
91 22 2482 6000
https://www.cipla.com

Settore/iHealthcare
SettoreDrug Manufacturers - General
Impiegati a tempo pieno32.323

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Umang Vohra B.E., M.B.A.MD, Global CEO & Executive Director174,9MN/D1971
Dr. Raju Sunil Mistry M.A., Ph.D.President & Global Chief People OfficerN/DN/D1965
Mr. Pradeep BhadauriaPresident & Chief Scientific OfficerN/DN/DN/D
Mr. Ashish AdukiaGlobal Chief Financial OfficerN/DN/DN/D
Mr. Dinesh Ramniranjan JainSenior VP & Head of Corporate FinanceN/DN/DN/D
Ms. Geena V. MalhotraGlobal Chief Technology OfficerN/DN/DN/D
Mr. Naveen BansalHead of Investor RelationsN/DN/DN/D
Mr. Rajendra Kumar ChopraCompliance Officer & Company Secretary15,3MN/DN/D
Ms. Heena KanalSenior Vice-President of Corporate CommunicationsN/DN/DN/D
Mr. Anurag MishraHead of Cipla FoundationN/DN/DN/D
Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in INR.

Descrizione

Cipla Limited, together with its subsidiaries, manufactures, develops, and sells pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New ventures segments. It also offers active pharmaceutical ingredients; and formulations in various therapeutic areas, such as MI, angina, heart failure, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, HIV, respiratory, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. In addition, the company provides respiratory products, including inhalers and nasal sprays, as well as other respiratory products consists of injectables and biosimilars. Further, it offers Easylax and Easylax L, a liquid paraffin for constipation. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.

Governance aziendale

L'ISS Governance QualityScore di Cipla Limited al 1 aprile 2024 è 4. I criteri di valutazione fondamentali sono revisione: 4; Consiglio di Amministrazione: 3; diritti degli azionisti: 1; retribuzione: 8.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.